Researchers discovered a relationship between chemotherapy-induced changes in gut bacteria and the harmful weight gain seen in breast cancer patients, perhaps leading the way to helping survivors avoid obesity-related illness later in life.
New Cornell research is providing a fresh view into the ways a common chemotherapy agent, etoposide, stalls and poisons the essential enzymes that allow cancer cells to flourish.